Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics. (Q52885510)
Jump to navigation
Jump to search
scientific article published in February 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics. |
scientific article published in February 2016 |
Statements
Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics (English)
Matthias Gaestel
Kay Hänggi
Gabriela Brumatti
Diep Chau
Nhu-Y N Nguyen
Lazaros Vasilikos
Lisanne M Spilgies
Denise A Heckmann
Chunyan Ma
Margherita Ghisi
Geoffrey M Matthews
Elisha de Valle
Donia M Moujalled
Sukhdeep Kaur Spall
Stefan P Glaser
Jennifer Richmond
Stephen M Condon
Raffi Gugasyan
Mark Guthridge
Lenka Munoz